The Multi-Kinase Inhibitor EC-70124 Is a Promising Candidate for the Treatment of FLT3-ITD-Positive Acute Myeloid Leukemia.

Lopez-Millan, Belen; Costales, Paula; Gutiérrez-Agüera, Francisco; Díaz de la Guardia, Rafael; Roca-Ho, Heleia; Vinyoles, Meritxell; Rubio-Gayarre, Alba; Safi, Rémi; Castaño, Julio; Romecín, Paola Alejandra; Ramírez-Orellana, Manuel; Anguita, Eduardo; Jeremias, Irmela; Zamora, Lurdes; Rodríguez-Manzaneque, Juan Carlos; Bueno, Clara; Morís, Francisco; Menendez, Pablo

Lopez-Millan, Belen; Costales, Paula; Gutiérrez-Agüera, Francisco; Díaz de la Guardia, Rafael; Roca-Ho, Heleia; Vinyoles, Meritxell; Rubio-Gayarre, Alba; Safi, Rémi; Castaño, Julio; Romecín, Paola Alejandra; Ramírez-Orellana, Manuel; Anguita, Eduardo; Jeremias, Irmela; Zamora, Lurdes; Rodríguez-Manzaneque, Juan Carlos; Bueno, Clara; Morís, Francisco; Menendez, Pablo.

Affiliation

Lopez-Millan B; Department of Biomedicine, Josep Carreras Leukemia Research Institute, School of Medicine, University of Barcelona, 08036 Barcelona, Spain.
Costales P; GENYO, Centre for Genomics and Oncological Research, Pfizer, Universidad de Granada, Junta de Andalucía, 18016 Granada, Spain.
Gutiérrez-Agüera F; Red Española de Terapias Avanzadas (TERAV), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain.
Díaz de la Guardia R; EntreChemSL, 33011 Oviedo, Spain.
Roca-Ho H; Department of Biomedicine, Josep Carreras Leukemia Research Institute, School of Medicine, University of Barcelona, 08036 Barcelona, Spain.
Vinyoles M; Department of Biomedicine, Josep Carreras Leukemia Research Institute, School of Medicine, University of Barcelona, 08036 Barcelona, Spain.
Rubio-Gayarre A; GENYO, Centre for Genomics and Oncological Research, Pfizer, Universidad de Granada, Junta de Andalucía, 18016 Granada, Spain.
Safi R; Department of Biomedicine, Josep Carreras Leukemia Research Institute, School of Medicine, University of Barcelona, 08036 Barcelona, Spain.
Castaño J; Department of Biomedicine, Josep Carreras Leukemia Research Institute, School of Medicine, University of Barcelona, 08036 Barcelona, Spain.
Romecín PA; Red Española de Terapias Avanzadas (TERAV), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain.
Ramírez-Orellana M; Department of Biomedicine, Josep Carreras Leukemia Research Institute, School of Medicine, University of Barcelona, 08036 Barcelona, Spain.
Anguita E; GENYO, Centre for Genomics and Oncological Research, Pfizer, Universidad de Granada, Junta de Andalucía, 18016 Granada, Spain.
Jeremias I; Department of Biomedicine, Josep Carreras Leukemia Research Institute, School of Medicine, University of Barcelona, 08036 Barcelona, Spain.
Zamora L; Red Española de Terapias Avanzadas (TERAV), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain.
Rodríguez-Manzaneque JC; Department of Biomedicine, Josep Carreras Leukemia Research Institute, School of Medicine, University of Barcelona, 08036 Barcelona, Spain.
Bueno C; Department of Biomedicine, Josep Carreras Leukemia Research Institute, School of Medicine, University of Barcelona, 08036 Barcelona, Spain.
Morís F; Red Española de Terapias Avanzadas (TERAV), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain.
Menendez P; Red Española de Terapias Avanzadas (TERAV), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain.